Literature DB >> 23359776

CPT-11 Chemotherapy Rescued A Patient with Atypical Sclerosing Epithelioid Fibrosarcoma from Emergent Condition.

Chun-Hua Pan1, Xi-Qun Han, Jian-Sheng Li.   

Abstract

Sclerosing epithelioid fibrosarcoma (SEF) is a rare and poorly defined variant of fibrosarcoma, but generally insensitive to chemotherapy and progresses with poor prognosis. We report the marvelous effect of irinotecan hydrochloride (CPT-11) chemotherapy in rescuing a patient with atypical SEF from emergent condition, who underwent recurrences after several treatment methods. Small dose of CPT-11 was administered to the patient, with which, the size of superficial mass (cervical lymph node) gradually decreased observed by the naked eyes in 5 days. X-ray and CT image proved a marked reduction in the size of the tumor. CPT-11 is valuable for the treatment of this aggressive sarcoma. In condition of emergency caused by sarcoma oppression, administering a tolerable small dose of topoisomerase I-inhibiting drug could be a beneficial choice.

Entities:  

Keywords:  CPT-11; Chemotherapy; Sclerosing epithelioid fibrosarcoma

Year:  2012        PMID: 23359776      PMCID: PMC3555278          DOI: 10.1007/s11670-012-0253-1

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  11 in total

1.  Relationship of DNA damage signaling to DNA replication following treatment with DNA topoisomerase inhibitors camptothecin/topotecan, mitoxantrone, or etoposide.

Authors:  Hong Zhao; Paulina Rybak; Jurek Dobrucki; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2011-12-02       Impact factor: 4.355

2.  Camptothecin (CPT) directly binds to human heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) and inhibits the hnRNP A1/topoisomerase I interaction.

Authors:  Daisuke Manita; Yuzuru Toba; Yoichi Takakusagi; Yuki Matsumoto; Tomoe Kusayanagi; Kaori Takakusagi; Senko Tsukuda; Kazunori Takada; Yoshihiro Kanai; Shinji Kamisuki; Kengo Sakaguchi; Fumio Sugawara
Journal:  Bioorg Med Chem       Date:  2011-10-05       Impact factor: 3.641

3.  Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions.

Authors:  J G Slatter; P Su; J P Sams; L J Schaaf; L C Wienkers
Journal:  Drug Metab Dispos       Date:  1997-10       Impact factor: 3.922

4.  Sclerosing epithelioid fibrosarcoma: a study of 16 cases and confirmation of a clinicopathologically distinct tumor.

Authors:  C R Antonescu; M K Rosenblum; P Pereira; A G Nascimento; J M Woodruff
Journal:  Am J Surg Pathol       Date:  2001-06       Impact factor: 6.394

5.  WRN helicase regulates the ATR-CHK1-induced S-phase checkpoint pathway in response to topoisomerase-I-DNA covalent complexes.

Authors:  Birija Sankar Patro; Rikke Frøhlich; Vilhelm A Bohr; Tinna Stevnsner
Journal:  J Cell Sci       Date:  2011-12-08       Impact factor: 5.285

6.  Toxicity of irinotecan (CPT-11) and hepato-renal dysfunction.

Authors:  S Y Ong; S J Clarke; J Bishop; H M Dodds; L P Rivory
Journal:  Anticancer Drugs       Date:  2001-08       Impact factor: 2.248

7.  Clinical benefit of second-line palliative chemotherapy in advanced soft-tissue sarcoma.

Authors:  Anna Minchom; Robin L Jones; Cyril Fisher; Omar Al-Muderis; Sue Ashley; Michelle Scurr; Vasilios Karavasilis; Ian R Judson
Journal:  Sarcoma       Date:  2010-05-20

8.  Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.

Authors:  Vasilios Karavasilis; Beatrice M Seddon; Susan Ashley; Omar Al-Muderis; Cyril Fisher; Ian Judson
Journal:  Cancer       Date:  2008-04-01       Impact factor: 6.860

9.  Sclerosing epithelioid fibrosarcoma. A variant of fibrosarcoma simulating carcinoma.

Authors:  J M Meis-Kindblom; L G Kindblom; F M Enzinger
Journal:  Am J Surg Pathol       Date:  1995-09       Impact factor: 6.394

10.  Mus81-mediated DNA cleavage resolves replication forks stalled by topoisomerase I-DNA complexes.

Authors:  Marie Regairaz; Yong-Wei Zhang; Haiqing Fu; Keli K Agama; Nalini Tata; Surbhi Agrawal; Mirit I Aladjem; Yves Pommier
Journal:  J Cell Biol       Date:  2011-11-28       Impact factor: 10.539

View more
  2 in total

1.  Sclerosing epithelioid fibrosarcoma.

Authors:  James W Patterson; Georgi Tchernev; Anastasiya Atanasova Chokoeva; Mark R Wick
Journal:  Wien Med Wochenschr       Date:  2016-09-15

Review 2.  ¹⁸F-fluorodeoxyglucose PET/CT features and correlations with histopathologic characteristics in sclerosing epithelioid fibrosarcoma.

Authors:  Yaping Luo; Wendi Hu; Huanwen Wu; Huadan Xue; Li Huo; Fang Li; Yupei Zhao; Menghua Dai
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.